Psychopharmacology
Unit Outlines

Psychopharmacology

AI Generated Intermediate 40 hours 8 topics

Learning Objectives

5 objectives
  • Understand the fundamental principles and history of psychopharmacology and its impact on brain function and behavior.
  • Explain the role of neurotransmitters and mechanisms of drug action on neural systems.
  • Describe pharmacokinetics and different routes of drug administration affecting drug efficacy.
  • Identify and differentiate major classes of psychoactive drugs and their clinical uses.
  • Analyze pharmacological treatments for mood, anxiety, psychotic, and substance use disorders.

Content Outline

Preview

Unit 1475: Psychopharmacology Fundamentals and Clinical Applications

1. Introduction to Psychopharmacology

1.1 Definition and Scope

  • Overview of psychopharmacology
  • Relationship between drugs, brain, and behavior

1.2 Historical Development

  • Early discoveries in psychopharmacology
  • Milestones in drug development

1.3 Categories of Psychoactive Drugs

  • Stimulants
  • Depressants
  • Hallucinogens
  • Others (e.g., mood stabilizers)

2. Neurotransmitters and Neuropharmacology

2.1 Major Neurotransmitters

  • Dopamine
  • Serotonin
  • Norepinephrine
  • GABA
  • Glutamate

2.2 Mechanisms of Drug Action

  • Agonists and antagonists
  • Reuptake inhibitors
  • Enzyme inhibitors

2.3 Neuropharmacology Methods

  • Measuring drug effects on neural activity
  • Neuroimaging and electrophysiological approaches

3. Drug Administration and Pharmacokinetics

3.1 Routes of Drug Administration

  • Oral
  • Intravenous
  • Intramuscular
  • Inhalation
  • Transdermal

3.2 Pharmacokinetics Processes

  • Absorption factors
  • Distribution in body tissues
  • Metabolism (liver enzymes, cytochrome P450 system)
  • Excretion (renal, biliary)

3.3 Influence on Drug Action

  • Bioavailability
  • Half-life and duration of effect
  • Drug interactions

4. Drug Classes in Psychopharmacology

4.1 Antidepressants

  • SSRIs, SNRIs, MAOIs, Tricyclics
  • Mechanisms and side effects

4.2 Antipsychotics

  • Typical versus atypical antipsychotics
  • Dopamine antagonism and side effects

4.3 Anxiolytics

  • Benzodiazepines
  • Non-benzodiazepine alternatives

4.4 Stimulants

  • Uses in ADHD and narcolepsy
  • Mechanisms and abuse potential

4.5 Mood Stabilizers

  • Lithium, anticonvulsants
  • Therapeutic uses and monitoring

5. Psychopharmacology of Mood Disorders

5.1 Depression Treatment

  • Antidepressant pharmacotherapy
  • Treatment-resistant depression considerations

5.2 Bipolar Disorder Treatment

  • Mood stabilizers and antipsychotics
  • Managing manic and depressive episodes

5.3 Impact on Quality of Life

  • Symptom management
  • Side effect profiles

6. Psychopharmacology of Anxiety Disorders

6.1 Pharmacological Interventions

  • Anxiolytics (benzodiazepines)
  • Antidepressants with anxiolytic effects
  • Beta-blockers for physical symptoms

6.2 Mechanisms of Action

  • GABAergic modulation
  • Serotonergic involvement

6.3 Efficacy and Risks

  • Dependence and tolerance
  • Withdrawal considerations

7. Psychopharmacology of Psychotic Disorders

7.1 Overview of Psychotic Disorders

  • Schizophrenia and related conditions

7.2 Antipsychotic Medications

  • Classification: Typical and atypical
  • Mechanisms (dopamine blockade, serotonin effects)

7.3 Side Effects and Management

  • Extrapyramidal symptoms
  • Metabolic syndrome
  • Long-term treatment challenges

8. Substance Use Disorders and Psychopharmacology

8.1 Pharmacotherapy Approaches

  • Detoxification medications
  • Relapse prevention agents
  • Craving reduction strategies

8.2 Medications by Substance Type

  • Alcohol: Disulfiram, naltrexone
  • Opioids: Methadone, buprenorphine
  • Stimulants: Experimental treatments

8.3 Integration with Behavioral Therapies

  • Combined treatment models
  • Monitoring and support
Unlock the full outline
Get the complete content outline, learning outcomes and assessment methods for Psychopharmacology.
KSh 20 one-off, or included with a plan

Learning Outcomes

Unlock the outline above to see learning outcomes.

Assessment Methods

Unlock the outline above to see assessment methods.

Quick Information

Unit Psychopharmacology
Difficulty Intermediate
Duration40 hours
Topics8
CreatedJul 20, 2026
GeneratedJul 20, 2026 11:04

Prerequisites

  • Basic knowledge of human biology and neuroanatomy
  • Introduction to pharmacology
  • Fundamentals of psychology or behavioral sciences

Recommended Resources

  • Stahl, S. M. (2013). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press.
  • Katzung, B. G., Masters, S. B., & Trevor, A. J. (2012). Basic and Clinical Pharmacology. McGraw-Hill Education.
  • Millan, M. J., et al. (2015). The Neurobiology and Treatment of Psychotic Disorders. Springer.
  • National Institute on Drug Abuse (NIDA) – https://www.drugabuse.gov/
  • Journal of Psychopharmacology – https://journals.sagepub.com/home/jop

Unit Topics

8
Introduction to Psychopharmacology
This topic provides an overview of psychopharmacology, including the study of how drugs affect the b...
Neurotransmitters and Neuropharmacology
This topic explores the role of neurotransmitters in the brain, the mechanisms of drug action on neu...
Drug Administration and Pharmacokinetics
This topic covers the various routes of drug administration, factors affecting drug absorption, dist...
Drug Classes in Psychopharmacology
This topic delves into the major classes of psychoactive drugs, such as antidepressants, antipsychot...
Psychopharmacology of Mood Disorders
This topic focuses on the pharmacological treatment of mood disorders like depression and bipolar di...
Psychopharmacology of Anxiety Disorders
This topic examines the pharmacological interventions for anxiety disorders, including anxiolytics,...
Psychopharmacology of Psychotic Disorders
This topic explores the pharmacological treatment of psychotic disorders such as schizophrenia, emph...
Substance Use Disorders and Psychopharmacology
This topic addresses the pharmacotherapy for substance use disorders, including the medications used...